September 2010. Volume 6. Number 3

Rotavirus vaccine is effective in producing an important reduction in the incidence of hospital admissions for gastroenteritis in children under five years in EE. UU.

 
 
 
 
 
 
 
 
 
 
Rating: 0 (0 Votes)
Newsletter Free Subscription
Regularly recieve most recent articles by e-mail
Subscribe
Print
Add to library
Discuss this article

AVC | Critically appraised articles

Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E y Paraxhar UD. Reduction in acute gastroenteritis hospitalizations amogn US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 Us states. J Infec Dis. 2010;201:1617-24.
Reviewers: Llerena Santa Cruz E1, Buñuel Álvarez JC2.
1Hospital Universitario Dr. Josep Trueta. Girona. España.
2Àrea Bàsica de Salut Girona-4. Institut Català de la Salut. Girona. España.
Correspondence: Enrique Llerena Santa Cruz. Email: santum7@yahoo.com
Reception date: 20/07/2010
Acceptance date: 19/07/2010
Publication date: 30/07/2010

Abstract

Authors’ conclusions: in children under five years living in EE. UU., the introduction of rotavirus vaccine was associated with a drastic reduction in the percentage of hospital admissions for gastroenteritis.

Reviewers’ commentary: in developed countries rotavirus vaccine is effective in reducing the percentage of hospital admissions. However, the economic cost associated with the vaccine makes difficult its inclusion in the routine vaccination schedule, despite its obvious clinical benefit.

How to cite this article

Llerena Santa Cruz E, Buñuel Álvarez JC. En Estados Unidos, la vacuna frente a rotavirus es efectiva para reducir de forma importante la incidencia de ingresos hospitalarios por gastroenteritis en niños menores de cinco años. Evid Pediatr. 2010;6:50.

AVC | Critically appraised articles

Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E y Paraxhar UD. Reduction in acute gastroenteritis hospitalizations amogn US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 Us states. J Infec Dis. 2010;201:1617-24.
Reviewers: Llerena Santa Cruz E1, Buñuel Álvarez JC2.
1Hospital Universitario Dr. Josep Trueta. Girona. España.
2Àrea Bàsica de Salut Girona-4. Institut Català de la Salut. Girona. España.
Correspondence: Enrique Llerena Santa Cruz. Email: santum7@yahoo.com
Reception date: 20/07/2010
Acceptance date: 19/07/2010
Publication date: 30/07/2010

How to cite this article

Llerena Santa Cruz E, Buñuel Álvarez JC. En Estados Unidos, la vacuna frente a rotavirus es efectiva para reducir de forma importante la incidencia de ingresos hospitalarios por gastroenteritis en niños menores de cinco años. Evid Pediatr. 2010;6:50.

References

  1. Pachón del Amo I, Martínez Aragón MV, Suárez B, Sánchez Fauquier B, Salmerón García F, Soler Soneira M et al.Situación epidemiológica de las gastroenteritis producidas por rotavirus. Recomendaciones de la vacunación frente a rotavirus [publicado: VI-2006][consultado: 18-VII-2010]. Disponible en:  http://www.avpap.org/gtdocencia/rotaviruscav.pdf 
  2. Aizpurua Galdeano P, García Vera C. Datos poblacionales de México sugieren efectividad de la vacuna frente al rotavirus en la disminución de la mortalidad por diarrea en niños pequeños. Evid Pediatr. 2010;6:34.
  3. Soares-Weiser K, MacLehose H, Ben-Aharon I, Goldberg E, Pitan F, Cunliffe N. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database of Systematic Reviews  2010, Issue 5. Art. No.: CD008521. DOI: 10.1002/14651858.CD008521.
  4. Milne RJ, Grimwood K. Budget impact and cost-effectiveness of including a pentavalent rotavirus vaccine in the New Zealand childhood immunization schedule. Value Health. 2009;12:888-98.
  5. Martin A, Batty A, Roberts JA, Standaert B. Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK. Vaccine. 2009;27:4520-8.
30/07/2010

Linked Comment